Implementation of a Consensus-Based Discharge Protocol for Preterm Infants With Lung Disease

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age0-1
SponsorBoston Children's Hospital

About this trial

The researchers have worked to create consensus recommendations among national efforts to help with the transition and coordination of care for preterm infants with lung disease around discharge from the neonatal intensive care unit to home. This study looks to evaluate implementation of the recommendations at Boston Children's Hospital and referring NICU's (Beth Israel Deaconess Medical Center and Brigham and Women's Hospital). Specifically, the research team will be looking at follow-up rates, healthcare utilization, and parental satisfaction/feedback with implementation of these guidelines.

Eligibility criteria

Qualifiers

Preterm infants born <32 weeks with at least mild BPD, defined as 28 days of respiratory support after birth.

Efforts will be made to include a mix of infants with mild, moderate, and severe BPD, including infants discharged on oxygen.

Disqualifiers

Discharge to a location other than home.

Infants with other congenital disease (cardiac, genetic, neurological) thought to contribute significantly to their respiratory disease.

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

50 Participants
are grouped into 2 trial groups

Sponsors and collaborators

Boston Children's Hospital

Lead sponsor

Beth Israel Deaconess Medical Center

Collaborator

Brigham and Women's Hospital

Collaborator